• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Bull WHO. Early response to the emergence of infuenza A(H7N9) virus in humans

Giuseppe

Emeritus
[Source: Bulletin of the World Health Organization, full PDF document: http://dx.doi.org/10.2471/BLT.13.125989 - Abstract, edited.]

Early response to the emergence of influenza A(H7N9) virus in humans

Sirenda Vong,a Michael O?Leary a & Zijian Feng b


Abstract

Problem

In 2003, China?s handling of the early stages of the epidemic of severe acute respiratory syndrome (SARS) was heavily criticized and generally considered to be suboptimal.

Approach

Following the SARS outbreak, China made huge investments to improve surveillance, emergency preparedness and response capacity and strengthen public health institutions. In 2013, the return on these investments was evaluated by investigating China?s early response to the emergence of avian influenza A(H7N9) virus in humans.


Local setting

Clusters of human infection with a novel infuenza virus were detected in China ? by national surveillance of pneumonia of unknown etiology ? on 26 February 2013.


Relevant changes

On 31 March 2013, China notifed the World Health Organization (WHO) of the first recorded human infections with A(H7N9) virus. Poultry markets ? which were rapidly identified as a major source of transmission of A(H7N9) to humans ? were closed down in the affected areas. Surveillance in humans and poultry was heightened and technical guidelines were quickly updated and disseminated.

The health authorities collaborated with WHO in risk assessments and risk communication. New cases were reported promptly and publicly.


Lessons learnt

The relevant infrastructures, surveillance systems and response capacity need to be strengthened in preparation for future emergencies caused by emerging or existing disease threats. Results of risk assessments and other data should be released promptly and publicly and such release should not jeopardize future publication of the data in scientifc journals. Coordination between public health and veterinary services would be stronger during an emergency if these services had already undertaken joint preparedness planning.

_____

a World Health Organization Ofce in China, 401 Dongwai Diplomatic Office Building, 23 Dongzhimenwai Dajie, Chaoyang District, Beijing 100600, China. b Chinese Centre or Disease Control and Prevention, Beijing, China.

Correspondence to Sirenda Vong (e-mail: vongs@wpro.who.int).

(Submitted: 11 June 2013 ? Revised version received: 22 November 2013 ? Accepted: 25 November 2013 ? Published online: 16 December 2013 )

doi: http://dx.doi.org/10.2471/BLT.13.125989


--
-----
 
Back
Top Bottom